Colonial Trust Advisors’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$641 Hold
50
﹤0.01% 690
2025
Q4
$450 Hold
50
﹤0.01% 671
2025
Q3
$864 Hold
50
﹤0.01% 645
2025
Q2
$469 Hold
50
﹤0.01% 668
2025
Q1
$356 Hold
50
﹤0.01% 651
2024
Q4
$583 Hold
50
﹤0.01% 647
2024
Q3
$1.03K Sell
50
-50
-50% -$1.15K ﹤0.01% 709
2024
Q2
$2.24K Buy
100
+25
+33% +$595 ﹤0.01% 673
2024
Q1
$2.06K Hold
75
﹤0.01% 801
2023
Q4
$2.29K Hold
75
﹤0.01% 697
2023
Q3
$2.37K Hold
75
﹤0.01% 701
2023
Q2
$3.06K Hold
75
﹤0.01% 694
2023
Q1
$2.79K Buy
75
+25
+50% +$981 ﹤0.01% 690
2022
Q4
$1.75K Buy
+50
New +$2.38K ﹤0.01% 742

Other funds holding NTLA